Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Refractory (Phase 1)
Asthma (Phase 1)
Astrocytoma (Phase 2)
Bone Marrow Cells (Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Merkel Cell (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 1/Phase 2)
Cervical Intraepithelial Neoplasia (Phase 1)
Colonic Neoplasms (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 2)
Conjunctival Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 1/Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Hamartoma (Phase 1/Phase 2)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 1)
Hemorrhagic Fever, Ebola (Phase 1)
Hepatitis B, Chronic (Phase 4)
HIV Infections (Phase 1/Phase 2)
Inflammatory Breast Neoplasms (Early Phase 1)
Influenza A Virus, H3N2 Subtype (Phase 2)
Influenza, Human (Phase 1)
Kidney Neoplasms (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Leukemia, Myelomonocytic, Chronic (Phase 1)
Liver Neoplasms (Phase 1/Phase 2)
Lung Diseases (Phase 1)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 1/Phase 2)
Lymphoma, B-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1/Phase 2)
Lymphoma, T-Cell (Phase 1)
Lymphoma, T-Cell, Cutaneous (Phase 1/Phase 2)
Medulloblastoma (Phase 1/Phase 2)
Melanoma (Phase 2)
Mesothelioma (Phase 1/Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Myeloproliferative Disorders (Phase 1)
Neoplasm Metastasis (Phase 1)
Neoplasm Recurrence, Local (Phase 1)
Neoplasms (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 1/Phase 2)
Neurofibroma (Phase 2)
Oligodendroglioma (Phase 2)
Osteosarcoma (Phase 1)
Ovarian Neoplasms (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 1/Phase 2)
Respiratory Distress Syndrome (Phase 1)
Sarcoma (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Smallpox (Phase 1)
Smoldering Multiple Myeloma (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Testicular Neoplasms (Phase 1/Phase 2)
Thrombocythemia, Essential (Phase 1)
Triple Negative Breast Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue